AIDS, HIV & STDs Market Research Reports & Industry Analysis
HIV (human immunodeficiency virus) is a virus that attacks the immune system, making it difficult for the body to fight off infection and diseases. HIV infection eventually results in AIDS (acquired immunodeficiency syndrome). This conversion to AIDS may result after 12 or 13 years after the initial infection. Initial HIV symptoms are similar to those of the flu and include fatigue, fever, weight loss, and swollen lymph nodes in the neck, armpits, or groin. Although there is currently no cure for HIV infection, a combination of medications called Highly Active AntiRetroviral Therapy (HAART), and now referred to as AART, helps prolong life in many people. As noted above, person with HIV infection may live for many years before developing any signs of AIDS.
While HIV/AIDS isn’t found in the headlines as much as during the disease’s discovery, more people in the United States are living with HIV/AIDS than ever before. While the incidence of HIV infection in the United States was approximately 0.25% of the population ten to fifteen years ago, it is now approximately 0.47% -- and the population in general has grown.
For this reason, it is important to understand the trends in HIV/AIDS epidemiology and the potential impacts on economies and societies as a whole. These trends emphasize the strategic need for preventive approaches, clinical testing technologies and products, and new therapeutics. Many market research reports provide such information.
AIDS, HIV & STDs Industry Research & Market Reports
-
Infectious Disease Diagnostics Market Report 2022-2032
... its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Growing Prevalence of Infectious Diseases, And Shift in ... Read More
-
Latin American Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application (Research, (Clinical- Cancer, Hematology), Industrial), End User (Biotech, Hospitals) - Forecast to 2027
... market is estimated to register a CAGR of 7.1% to reach USD 379 million by 2027 from USD 269 million in 2022. The growing prevalence of cancer and HIV/ AIDS, growing research activities which adopt ... Read More
-
The World Market for Molecular Diagnostics Tests, 11th Edition
... NIPT, Other) Blood Banking Molecular Diagnostics Markets Transplantation Molecular Diagnostic Markets Regional Molecular Diagnostics Markets (North America, Europe, Asia, Global) This report is published as the industry experienced accelerated installed bases and new product introductions. ... Read More
-
Global HIV/HBV/HCV Test Kits Market - 2022-2029
... a CAGR of 6.8 % during the forecast period (2022-2029). HIV/HBV/HCV test is a test of qualitative detection and differentiation of hepatitis B surface antigen (HBsAg) and antibodies to HIV-1, HIV-2, Treponema pallidum (Tp), and ... Read More
-
Antiviral Drugs Market Report 2022-2032
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Introduction of Blockbuster Drugs to Boost Market Growth Antiviral medicines ... Read More
-
HIV and HBV Therapies Market Report 2022-2032
... industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Factors Such as Rising Prevalence of ... Read More
-
Africa HIV Treatment Drugs Market 2023-2027
... during the forecast period. Our report on the HIV treatment drugs market in Africa provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 ... Read More
-
Global Sexually Transmitted Diseases (STD) Testing Market Size study & Forecast, by Disease Type (Chlamydia, Gonorrhea, Herpes Simplex Virus, Syphilis, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), and Other Diseases) and Location of Testing (Laboratory Testing, and Point-of-care (POC) Testing) and Regional Analysis, 2022-2029
... Testing, and Point-of-care (POC) Testing) and Regional Analysis, 2022-2029 Global Sexually Transmitted Diseases (STD) Testing Market is valued approximately USD 96.06 billion in 2021 and is anticipated to grow with a healthy growth rate of ... Read More
-
Genital Herpes - Epidemiology Forecast - 2032
... EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan, and China. Geography Covered The United States EU5 (Germany, France, Italy, Spain, and the United Kingdom) Japan China Study Period: 2019-2032 Genital Herpes understanding The ... Read More
-
Genital Herpes - Market Insight, Epidemiology And Market Forecast - 2032
... the Genital Herpes trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), Japan and China. The Genital Herpes market report provides emerging drugs, Genital Herpes market share of the individual cancer ... Read More
-
Chlamydia - Pipeline Insight, 2022
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Chlamydia Understanding ... Read More
-
Genital Herpes - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Sexually Transmitted Diseases Diagnostics Market Insights, Competitive Landscape and, Market Forecast - 2027
... AND OTHERS), BY TESTING (LABORATORY DEVICES [PCR, LTERAL FLOW READERS IMMUNOCHROMATOGRAPHIC ASSAY, FLOW CYTOMETERS, ABSORBANCE MICROPLATE READERS ENZYME LINKED IMMUNOSORBENT ASSAY, AND OTHERS] AND POINT OF CARE DEVICES [PHONE CHIPS, PORTABLE/BENCH, AND DIAGNOSTIC KITS]), BY ... Read More
-
Kaposi Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Kaposi Sarcoma (Infectious Disease) pipeline landscape. Kaposi's sarcoma is a cancer that causes patches of abnormal tissue to grow under the skin, in the lining of the mouth, nose, and ... Read More
-
Cell Counting Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... significant impact on the adoption of cell counting products and consumables. The pandemic witnessed increased adoption of cell counting devices, as osteopenia and lymphopenia are the potential indicators of COVID-19. The study published in BMC ... Read More
-
Infectious Disease Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... USD 50,345.74 million. The infectious disease diagositcs market is expected to register a CAGR of 3.79% over the forecast period (2022-2027). The market for infectious illness diagnostics has been considerably affected by the COVID-19 epidemic. ... Read More
-
Herpes Labialis (Oral Herpes) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs In Development, 2022, provides an overview of the Herpes Labialis (Oral Herpes) (Infectious Disease) pipeline landscape. Oral herpes is an infection of the lips, mouth, or gums due to the herpes simplex virus. Oral ... Read More
-
Vaccine Adjuvants Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... exports due to facility closures during the COVID-19 pandemic had a short-term adverse impact on the market's growth in the pandemic's preliminary phase due to supply chain disruptions and the unavailability of human resources. However, ... Read More
-
HIV/AIDS Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... dramatic decline in HIV testing and, as a consequence, a much lower number of new HIV diagnoses. In May 2022, an article published titled "COVID Caused Drop-in HIV Testing, Diagnoses" stated that the Centers for ... Read More
-
Global Warts Therapeutics Market - 2022-2029
... during the forecast period (2022-2029). Warts are skin growth that is caused by the human papillomavirus (HPV). It may persist for years and recurs at the same or different sites, even after treatment. Some factors ... Read More
-
Global self-testing kits market trends and forecasts
... estimates from 2022, and projections of compound annual growth rates (CAGRs) through 2027 (forecast period 2022–2027) and examines regional markets for self-testing kits. This report will highlight the current and future market potential of self-testing ... Read More
-
Herpes Simplex Virus Treatment Market Size, Share & Trends Analysis Report By Treatment (HSV-1, HSV-2), By Drug, By Vaccine, By Route Of Administration, By End-use, By Region, And Segment Forecasts, 2022 - 2030
... Virus Treatment Market Growth & Trends The global herpes simplex virus treatment market size is expected to reach USD 3.75 billion by 2030, according to a new report by Grand View Research, Inc., expanding at ... Read More
-
HIV Diagnostics Market
... 2022-2032. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision. ... Read More
-
Point of Care (PoC) Molecular Diagnostics Market Analysis and Forecast to 2031: By Technology (PCR, In Situ Hybridization, Sequencing, Isothermal Amplification), By Application (Infectious Disease, {Flu, Respiratory Syncytial Virus (RSV), Tuberculosis (TB), HIV, Gonorrhoea, Chlamydia, Hepatitis C, Hepatitis B}, Oncology, Hematology), By End-use (Hospitals, Clinics) and Region
... Hepatitis C, Hepatitis B}, Oncology, Hematology), By End-use (Hospitals, Clinics) and Region The global pulse oximeter market was valued at USD 2.2 billion in 2021 and it is anticipated to grow up to USD 2.6 ... Read More
-
Middle East and Africa Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type (Anti-Viral, Anti-Bacterial, Anti-Fungal, and Others), Range (Narrow Spectrum and Broad Spectrum), Route of Administration (IV, Oral, Topical, and Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others)
... Topical, and Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others) The MEA Anti-infective agents market was valued at US$ 8,188.65 million in ... Read More
Research Assistance
